Your browser doesn't support javascript.
loading
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
Di Marco, Maurizio; Scilletta, Sabrina; Miano, Nicoletta; Marrano, Nicola; Natalicchio, Annalisa; Giorgino, Francesco; Di Mauro, Stefania; Filippello, Agnese; Scamporrino, Alessandra; Tribulato, Paola; Bosco, Giosiana; Di Giacomo Barbagallo, Francesco; Scicali, Roberto; Milluzzo, Agostino; Ballirò, Teresa; Frittitta, Lucia; Castellino, Pietro; Purrello, Francesco; Piro, Salvatore; Di Pino, Antonino.
  • Di Marco M; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Scilletta S; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Miano N; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Marrano N; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70124, Bari, Italy.
  • Natalicchio A; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70124, Bari, Italy.
  • Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70124, Bari, Italy.
  • Di Mauro S; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Filippello A; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Scamporrino A; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Tribulato P; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Bosco G; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Di Giacomo Barbagallo F; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Scicali R; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Milluzzo A; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Ballirò T; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Frittitta L; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Castellino P; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Purrello F; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Piro S; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. salvatore.piro@unict.it.
  • Di Pino A; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Cardiovasc Diabetol ; 22(1): 344, 2023 12 13.
Article en En | MEDLINE | ID: mdl-38093293
ABSTRACT

BACKGROUND:

In the last years, the classical pattern of diabetic kidney disease (DKD) has been partially overcome, because of the uncovering of a new DKD phenotype with significant renal dysfunction without presence of albuminuria the non-albuminuric DKD (NA-DKD). To date, the cardiovascular risk associated with this phenotype is still debated. We investigated the cardiovascular risk and renal injury profile of NA-DKD subjects in comparison with other DKD phenotypes.

METHODS:

Pulse wave velocity (PWV), intima-media thickness, presence of carotid atherosclerotic plaque, renal resistive index (RRI), and a panel of urinary biomarkers of kidney injury were evaluated in 160 subjects with type 2 diabetes, stratified according to estimated glomerular filtration rate (eGFR) and urinary albumin to creatinine ratio (UACR) into four groups controls (UACR < 30 mg/g and eGFR ≥ 60 mL/min/1.73 m2), A-DKD (Albuminuric-DKD, UACR ≥ 30 mg/g and eGFR ≥ 60 mL/min/1.73 m2), NA-DKD (UACR < 30 mg/g and eGFR < 60 mL/min/1.73 m2), AL-DKD (Albuminuric and Low eGFR-DKD; UACR ≥ 30 mg/g and eGFR < 60 mL/min/1.73 m2).

RESULTS:

Subjects with NA-DKD showed a higher PWV (11.83 ± 3.74 m/s vs. 10.24 ± 2.67 m/s, P = 0.045), RRI (0.76 ± 0.11 vs. 0.71 ± 0.09, P = 0.04), and prevalence of carotid atherosclerotic plaque (59% vs. 31%, P = 0.009) compared with controls. These characteristics were similar to those of subjects with AL-DKD, whereas the profile of A-DKD subjects was closer to controls. After multiple regression analyses, we found that RRI, that is in turn influenced by eGFR (ß = - 0.01, P = 0.01), was one of the major determinants of PWV (ß = 9.4, P = 0.02). Urinary TreFoil Factor 3, a marker of tubular damage, was higher in NA-DKD subjects vs. controls (1533.14 ± 878.31 ng/mL vs. 1253.84 ± 682.17 ng/mL, P = 0.047). Furthermore, after multiple regression analyses, we found that urinary osteopontin was independently associated with PWV (ß = 2.6, P = 0.049) and RRI (ß = 0.09, P = 0.006).

CONCLUSIONS:

Our data showed a worse cardiovascular and renal injury profile in NA-DKD subjects. This finding emphasizes the central role of eGFR in the definition of cardiovascular risk profile of diabetic subjects together with albuminuria.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Placa Aterosclerótica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Placa Aterosclerótica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article